This announcement is a separate document:
キャンバス：2月9日公表『CBP501の米国における次相臨床試験予定 及び欧州における臨床第3相試験準備について』に関する補足Q&A公表の件
CanBas: Supplementary Q&A announcement on “CBP501 Next Phase Clinical Trial Schedule in the US and Clinical Phase 3 Clinical Trial Preparation in Europe” published on 2/9
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.